Driving cell and gene therapy success in Asia Pacific and beyond
Cell and gene therapies (CGT) represent a growing frontier in medicine, with the potential to transform the treatment of cancer, genetic diseases and more. However, developing these cutting-edge therapies requires highly skilled experience in navigating the complexities of clinical development, manufacturing, analytical testing and commercialization on a global scale.
At a recent panel discussion in Singapore, Labcorp’s scientific leaders in CGT discussed the keys to enabling clinical success for CGTs worldwide. For early-stage researchers and startups embarking on CGT development, panelists emphasized the importance of planning ahead for manufacturing needs and seeking guidance from those experienced in the space. They also highlighted the value of biomarker-driven strategies and companion diagnostics in expediting development.
Collaboration between academia, pharma and contract research organizations can significantly advance these biomarker-driven approaches. By combining real-world expertise, datasets and resources across sectors, effective patient selection and monitoring solutions can be implemented. Speakers shared examples of partnerships that allowed predictive biomarkers to be identified early and companion diagnostic assays to be co-developed alongside therapies, accelerating approval.
Deepening our commitment to CGT growth in APAC
The Asia Pacific (APAC) region presents unique opportunities and challenges for expanding CGT access globally. Labcorp is focusing its efforts on expanding CGT development in China and beyond by providing integrated lab testing solutions for companies developing CAR-T and gene therapies and more. With on-the-ground experts in central lab services, biomarkers, immunology, safety and efficacy testing, Labcorp helps developers successfully navigate regional clinical trial and regulatory environments.
In addition, our China-based team offers centralized laboratory services, bioanalytical testing, biomarker development, immunology and immunotoxicology testing to support CGT programs across the APAC region.
Download the presentation to learn more about our global CGT solutions and explore our capabilities.